Literature DB >> 8608461

Acute myocardial infarction in a healthy mother using bromocriptine for milk suppression.

L Hopp1, A B Weisse, L Iffy.   

Abstract

A 34-year-old mother developed acute myocardial infarction (MI) 10 days postpartum while taking bromocriptine for ablactation. Her only known risk factor was moderate hypercholesterolemia. The initial coronary arteriogram revealed minimal irregularities of the mid- and distal left anterior descending (LAD) artery, but severe narrowing of a large first diagonal branch of the LAD. Repeat coronary arteriography, performed two months later for recurrent chest pain, showed no significant change in the LAD. There was, however, a marked improvement in the first diagonal branch. To the authors' knowledge this is the 10th report of MI in a patient using bromocriptine postpartum for milk suppression and only the second one to implicate by its investigations the role of vasospasm in the coronary vessels at the cause of the infarction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8608461

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  8 in total

1.  Spontaneous coronary artery dissection during cabergoline therapy.

Authors:  Nishaki Kiran Mehta; Samir Malkani; Ira Ockene
Journal:  Tex Heart Inst J       Date:  2012

Review 2.  Pregnancy-associated spontaneous coronary artery dissection: impact of medical treatment. Case report and systematic review.

Authors:  M Maeder; P Ammann; G Drack; H Rickli
Journal:  Z Kardiol       Date:  2005-12

Review 3.  Managing prolactin-secreting adenomas during pregnancy.

Authors:  Syed Ali Imran; Ehud Ur; David B Clarke
Journal:  Can Fam Physician       Date:  2007-04       Impact factor: 3.275

4.  Spontaneous coronary artery dissection in the postpartum period.

Authors:  B J L Van den Branden; W A J Bruggeling; H M A Corbeij; P H J M Dunselman
Journal:  Neth Heart J       Date:  2008-12       Impact factor: 2.380

Review 5.  Case report and mini literature review: anesthetic management for severe peripartum cardiomyopathy complicated with preeclampsia using sufetanil in combined spinal epidural anesthesia.

Authors:  Pradipta Bhakta; Pragnyadipta Mishra; Anamika Bakshi; Vijay Langer
Journal:  Yonsei Med J       Date:  2011-01       Impact factor: 2.759

Review 6.  Effects of bromocriptine in peripartum cardiomyopathy: a systematic review and meta-analysis.

Authors:  Angkawipa Trongtorsak; Veraprapas Kittipibul; Sunita Mahabir; Michel Ibrahim; Garly R Saint Croix; Gabriel A Hernandez; Sandra Chaparro
Journal:  Heart Fail Rev       Date:  2021-11-01       Impact factor: 4.214

7.  Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.

Authors:  Arash Haghikia; Edith Podewski; Dominik Berliner; Kristina Sonnenschein; Dieter Fischer; Christiane E Angermann; Michael Böhm; Philipp Röntgen; Johann Bauersachs; Denise Hilfiker-Kleiner
Journal:  Clin Res Cardiol       Date:  2015-05-31       Impact factor: 5.460

8.  Cabergoline as an adjuvant to standard heart failure treatment in peripartum cardiomyopathy: A case report and review of the literature.

Authors:  Giuseppe Caruso; Annalisa Scopelliti; Sara Scaramuzzino; Giuseppina Perrone; Paola Galoppi; Innocenza Palaia; Ludovico Muzii; Pierluigi Benedetti Panici; Roberto Brunelli
Journal:  Case Rep Womens Health       Date:  2020-12-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.